Longer Read
An age old problem
Communication – with patients, families and carers, as well as with other health professionals – is key when it comes to managing pain in older people living in residential aged …
Covid: Has it really been so long?
It’s now been four years since the Covid-19 pandemic was declared. It has driven changes in pharmacy, as in so much of healthcare, and indeed society. Where are we currently …
Achoo: advice for navigating cough and cold season
The cough and cold category is the perfect opportunity to tailor treatment and self-care advice, differentiating the pharmacy from other retailers, writes Leanne Philpott KEY POINTS: Adults have on average …
No ‘golden ticket’ for reducing risky meds harm
High-risk prescribing in aged care residents under the spotlight, as Australian experts weigh in on the role of embedded pharmacists Polypharmacy and the use of potentially inappropriate medicines (PIMs) in …
Bringing menopause out of the shadows
The overwhelming list of symptoms, treatment choices, and misinformation can leave many patients muddled when it comes to menopause, writes Leanne Philpott Menopause isn’t ‘secret women’s business’—at least it shouldn’t …
‘It’s all about quality of life at the end.’
Community pharmacists can help people with terminal illness manage medicines, pain and other symptoms, but they are currently underutilised, say researchers Community based pharmacists can help support people who have …
Actions speak louder than words
Pharmacy owners need to see a “fair” Eighth Community Pharmacy Agreement signed before they will feel confident in future viability of the sector While industry leaders are continuing to negotiate …
‘An exciting time’: a new era in treating migraine
New treatment options and changes to the scheduling of existing medicines are heralding changes to the outlook for patients who experience migraine, writes Megan Haggan “It’s an exciting time in …
Opioids, overdose and naloxone: starting the conversation
Risk factors for overdose are surprisingly common among patients taking prescribed opioids, but how can pharmacists best approach conversations around safety and prevention? Sheshtyn Paola investigates Most people know that …
Ozempic isn’t approved for weight loss in Australia. So how are people accessing it?
Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? The Conversation’s experts, Andrew Bartlett, Jessica Pace and …
Cardiovascular risks and Covid-19
New research confirms the benefits of vaccination, writes Glen Pyle, Dalhousie University Covid-19 is a respiratory disease. Yet, from the earliest days of the pandemic, the cardiovascular risks associated with …
Regulatory barriers may not be enough to stop CWH, Sigma merger
Sigma Healthcare’s merger with Chemist Warehouse may go ahead despite competition concerns Associate Professor of Finance at RMIT, Angel Zhong, warns Corporate Australia loves a big merger. And amid a growing …